Cargando…
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901210/ https://www.ncbi.nlm.nih.gov/pubmed/33622313 http://dx.doi.org/10.1186/s12943-021-01331-9 |
| _version_ | 1783654355225804800 |
|---|---|
| author | Fang, Wenfeng Jin, Haoxuan Zhou, Huaqiang Hong, Shaodong Ma, Yuxiang Zhang, Yaxiong Su, Xiaofan Chen, Longyun Yang, Yunpeng Xu, Shengqiang Liao, Yuwei He, Yuming Zhao, Hongyun Huang, Yan Gao, Zhibo Zhang, Li |
| author_facet | Fang, Wenfeng Jin, Haoxuan Zhou, Huaqiang Hong, Shaodong Ma, Yuxiang Zhang, Yaxiong Su, Xiaofan Chen, Longyun Yang, Yunpeng Xu, Shengqiang Liao, Yuwei He, Yuming Zhao, Hongyun Huang, Yan Gao, Zhibo Zhang, Li |
| author_sort | Fang, Wenfeng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7901210 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79012102021-03-01 Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer Fang, Wenfeng Jin, Haoxuan Zhou, Huaqiang Hong, Shaodong Ma, Yuxiang Zhang, Yaxiong Su, Xiaofan Chen, Longyun Yang, Yunpeng Xu, Shengqiang Liao, Yuwei He, Yuming Zhao, Hongyun Huang, Yan Gao, Zhibo Zhang, Li Mol Cancer Letter to the Editor BioMed Central 2021-02-23 /pmc/articles/PMC7901210/ /pubmed/33622313 http://dx.doi.org/10.1186/s12943-021-01331-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter to the Editor Fang, Wenfeng Jin, Haoxuan Zhou, Huaqiang Hong, Shaodong Ma, Yuxiang Zhang, Yaxiong Su, Xiaofan Chen, Longyun Yang, Yunpeng Xu, Shengqiang Liao, Yuwei He, Yuming Zhao, Hongyun Huang, Yan Gao, Zhibo Zhang, Li Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer |
| title | Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer |
| title_full | Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer |
| title_fullStr | Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer |
| title_full_unstemmed | Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer |
| title_short | Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer |
| title_sort | intratumoral heterogeneity as a predictive biomarker in anti-pd-(l)1 therapies for non-small cell lung cancer |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901210/ https://www.ncbi.nlm.nih.gov/pubmed/33622313 http://dx.doi.org/10.1186/s12943-021-01331-9 |
| work_keys_str_mv | AT fangwenfeng intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT jinhaoxuan intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT zhouhuaqiang intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT hongshaodong intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT mayuxiang intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT zhangyaxiong intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT suxiaofan intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT chenlongyun intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT yangyunpeng intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT xushengqiang intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT liaoyuwei intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT heyuming intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT zhaohongyun intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT huangyan intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT gaozhibo intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer AT zhangli intratumoralheterogeneityasapredictivebiomarkerinantipdl1therapiesfornonsmallcelllungcancer |